Ms Heather Renee Silicato, MS, OTR/L | |
300 Hall Pl, Milford, DE 19963-1809 | |
(302) 396-0473 | |
(302) 258-1853 |
Full Name | Ms Heather Renee Silicato |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 300 Hall Pl, Milford, Delaware |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154641843 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | U1-0001172 (Delaware) | Primary |
Provider Name | Mabcf Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1538705488 PECOS PAC ID: 7719380484 Enrollment ID: O20210720000630 |
News Archive
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.
Lannett Company, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2011 for the company's 505(b)(2) New Drug Application for Morphine Sulfate Oral Solution
For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Heather Renee Silicato, MS, OTR/L 563 Raughley Hill Rd, Harrington, DE 19952-3171 Ph: (302) 632-8707 | Ms Heather Renee Silicato, MS, OTR/L 300 Hall Pl, Milford, DE 19963-1809 Ph: (302) 396-0473 |
News Archive
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.
Lannett Company, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2011 for the company's 505(b)(2) New Drug Application for Morphine Sulfate Oral Solution
For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).
› Verified 3 days ago
Mrs. Dorrice Burns, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Marvel Rd, Milford, DE 19963 Phone: 302-430-7026 | |
Dynamic Therapy Services Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 329 Mullet Run, Milford, DE 19963 Phone: 302-424-1810 | |
John Spillane, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 906 Lakeview Ave, Milford, DE 19963 Phone: 302-684-4950 Fax: 302-684-8931 | |
Bradford Allison Melvin, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 100 Delaware Veterans Blvd, Milford, DE 19963 Phone: 302-424-6000 | |
Tracy J Dissinger, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 329 Mullet Run, Milford, DE 19963 Phone: 302-424-1810 Fax: 302-424-3092 | |
Logan Shuttleworth, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 21 W Clarke Ave Ste 1500, Milford, DE 19963 Phone: 302-491-6529 Fax: 302-503-7160 |